| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Erspamer V |
Il sistema cellulare enterocromaffine e l'enteramina (5-idrossitriptam... |
Rendic sc. farmital. |
1954 |
| Apter JT, Pfeiffer CC |
Effect of hallucinogenic drugs on the electroretinogram |
Amer. J. Ophthalm. |
1956 |
| De Alvarez do Toledo LG, ... |
Psicoanálisis y dietilamida del ácido lisérgico (LSD-25). Fundamentos... |
|
1957 |
| Apter JT, Pfeiffer CC |
The effect of the hallucinogenic drugs LSD-25 and mescaline on the ele... |
Ann. N.Y. Acad. Sc. |
1957 |
| Apter JT |
Analeptic action of lysergic acid diethylamide (LSD-25) against pentob... |
Arch. Neurol. Psychi... |
1958 |
| Apter JT |
LSD-25 versus pentobarbital sodium |
Fed. Proc. |
1958 |
| Apter JT |
Prolonged survival of the isolated retina induced by drugs: strychnin... |
Arch. Ophth. |
1958 |
| Fremont-Smith F, Abramson... |
Introductory remarks |
The Use of LSD in Ps... |
1960 |
| Richards WA (Robertson J ... |
Report on Experiment Five : Uncontainable Joy |
The Ecstasic Adventu... |
1968 |
| Barr HL, Langs RJ, Holt R... |
LSD : Personality And Experience |
|
1972 |
| Connell PH |
Hallucinogens |
Side effects of drug... |
1972 |
| Tarshis MS |
The LSD Controversy: an Overview |
Amer J Psychiat |
1973 |
| Itil TM, Saletu B, Akpina... |
Classification of Psychotropic Drugs Based on Digital Computer Sleep P... |
Mod.Probl.Pharmacops... |
1974 |
| Brimblecombe RW |
Lysergic acid derivatives |
Hallucinogenic agent... |
1975 |
| Fanchamps A |
Some Compounds With Hallucinogenic Activity |
Handbook of Experime... |
1978 |
| Martin WR |
The Nature of Opioid and LSD Receptors: Structural Activity Relationsh... |
QUASAR. Quantitative... |
1978 |
| Kobel H, Sanglier JJ |
Ergot Alkaloids |
unknown |
1978 |
| Pieri L, Keller HH, Laure... |
Behavioral, Neurochemical, and Electrophysiological Effects of Lisurid... |
Lisuride and Other D... |
1983 |
| Keller HH, Bonetti EP, Pi... |
Lisuride-Induced Mounting Behavior and Effects on the Monoaminergic Sy... |
Lisuride and Other D... |
1983 |
| De Souza EB, Battaglia G |
Effects of MDMA and MDA on brain serotonin neurons: evidence from neur... |
NIDA Res Monogr |
1989 |
| Molliver ME, Mamounas LA,... |
Effects of neurotoxic amphetamines on serotonergic neurons: immunocyto... |
NIDA Res Monogr |
1989 |
| Nichols DE, Oberlender R |
Structure-activity relationships of MDMA-like substances |
NIDA Res Monogr |
1989 |
| De Souza EB, Battaglia G,... |
Neurotoxic effect of MDMA on brain serotonin neurons: evidence from ne... |
Ann N Y Acad Sci |
1990 |
| Greer GR,Tolbert R |
The Therapeutic Use of MDMA |
Ecstasy: The clinica... |
1990 |
| Tronick EZ, Beeghly M |
Effects of prenatal exposure to cocaine on newborn behavior and develo... |
Office for Substance... |
1992 |
| O'Callaghan JP, Miller DB |
Quantification of reactive gliosis as an approach to neurotoxicity ass... |
NIDA Res Monogr |
1993 |
| Smith DE, Seymour RB |
LSD: History and Toxicity |
Psychiatric Annals |
1994 |
| Axt KJ, Mamounas LA, Moll... |
Structural Features of Amphetamine Neurotoxicity in the Brain. Ampheta... |
Academic Press San D... |
1994 |
| Szara S |
Are Hallucinogens Psychoheuristic? |
NIDA Research Monogr... |
1994 |
| Westkaemper RB, Glennon R... |
Molecular Modeling of the Interaction of LSD and Other Hallucinogens W... |
NIDA Research Monogr... |
1994 |
| Sanders-Bush E |
Neurochemical Evidence That Hallucinogenic Drugs Are 5=HT1C Receptor A... |
NIDA Research Monogr... |
1994 |
| Shih JC, Chen K, Gallaher... |
Structure and Function of Serotonin 5-HT2 Receptors |
NIDA Research Monogr... |
1994 |
| Rudgley R |
The archaic use of hallucinogens in Europe: an archaeology of altered ... |
Addiction |
1995 |
| Brent J |
Monoamine Oxidase Inhibitors and the Serotonin Syndrome |
Clinical Management ... |
1998 |
| Alper KR, Beal D, Kaplan ... |
A contemporary history of ibogaine in the United States and Europe |
Alkaloids Chem Biol |
2001 |
| Nichols DE |
LSD and Its Lysergamide Cousins |
Heffter Review |
2001 |
| Nolin PC, Kenny C |
CANNABIS: OUR POSITION FOR A CANADIAN PUBLIC POLICY |
Senate Special Commi... |
2002 |
| Cole MD |
The Analysis of LSD |
The Analysis of Cont... |
2003 |
| Gebhardt DO |
Off-label administration of drugs to healthy military personnel. Dubio... |
J Med Ethics |
2005 |
| Dyck E |
'Hitting Highs at Rock Bottom': LSD Treatment for Alcoholism, 1950-197... |
Social History of Me... |
2006 |
| Tupper KW |
Entheogenic healing: The spiritual effects and therapeutic potential o... |
Book: The Healing Po... |
2009 |
| Frenk H, Dar R |
If the data contradict the theory, throw out the data: Nicotine addict... |
Harm Reduct J |
2011 |
| Russo EB, Hohmann AG |
Role of Cannabinoids in Pain Management |
Comprehensive Treatm... |
2013 |
| Caldwell HK, Albers HE |
Oxytocin, Vasopressin, and the Motivational Forces that Drive Social B... |
Curr Top Behav Neuro... |
2015 |
| Schifano F, Orsolini L, P... |
NPS: Medical Consequences Associated with Their Intake |
Curr Top Behav Neuro... |
2016 |
| Green TC, Gilbert M |
Counterfeit Medications and Fentanyl |
JAMA Intern Med |
2016 |
| Papaseit E, Moltó J, Muga... |
Clinical Pharmacology of the Synthetic Cathinone Mephedrone |
Curr Top Behav Neuro... |
2016 |
| Nichols DE |
Chemistry and Structure-Activity Relationships of Psychedelics |
Curr Top Behav Neuro... |
2017 |
| Moosmann B, Auwärter V |
Designer Benzodiazepines: Another Class of New Psychoactive Substances |
Handb Exp Pharmacol |
2018 |
| Canal CE |
Serotonergic Psychedelics: Experimental Approaches for Assessing Mecha... |
Handb Exp Pharmacol |
2018 |
| Wallach J, Brandt SD |
1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances |
Handb Exp Pharmacol |
2018 |
| Bodnár KJ, Kakuk P |
Research ethics aspects of experimentation with LSD on human subjects:... |
Med Health Care Phil... |
2018 |
| Passie T, Brandt SD |
Self-Experiments with Psychoactive Substances: A Historical Perspectiv... |
Handb Exp Pharmacol |
2018 |
